Revolutionising Personalised Skin Care: Is D2C the Future of Pharmaceutical Therapeutics?

1 min read

Key Takeaways:

  • Skin + Me is revolutionising the personalised skin care industry by providing direct-to-consumer (D2C) personalised skin treatments.
  • Users can have online medical consultations with qualified dermatologists and pharmacists.
  • Skin + Me provide prescription-based therapy creams, allowing skin health patients to receive consistent guidance, treatment, and support.
  • This startup’s approach to personalised skincare may indicate a future trend in pharmaceutical therapeutics.

The skincare industry has been undergoing significant changes, many driven by innovative startups like Skin + Me. Located in London, England, Skin + Me is a D2C (Direct-to-Consumer) brand that’s rapidly establishing its place in the health care, pharmaceutical, and therapeutics industries. The startup offers personalised skin treatments for achieving ‘feel-great skin’, backed by a team of dermatologists, pharmacists, and D2C professionals.

The startup was founded in January 2018 by Horatio Cary, James Mishreki, Mike Passey, Philip Wilkinson, and Rachel Jones. Skin + Me’s unique approach in providing prescription-based therapy creams along with consistent guidance, treatment, and support is setting a new standard in the skincare industry. This hybrid model, which incorporates both medication and consultation, offers customers a level of convenience and personalised care unseen in traditional models.

What sets Skin + Me apart is its seamless synthesis of online medical consultation and customised skincare solutions. By taking a predominantly digital model, they are addressing some of the biggest barriers in effective skincare – access to professional advice and personalised treatment. With their handy website, users can easily book consultations with seasoned professionals and receive personalised skincare products based on their skin’s unique needs and states. This level of customisation and personalisation is something that is slowly becoming the norm within the skincare industry, and Skin + Me are at its forefront.

Read more from UKT News:  Startup Showcase: Life Lessons Education - Building Stronger Futures with Technology

Additionally, Skin + Me’s commitment to continued support is something that truly distinguishes them within this burgeoning market. Not only does a user receive their bespoke skincare product, but they are also presented with ongoing treatment plans and the ability to check-in with professionals as needed. In this way, Skin + Me isn’t just a product-based brand; it’s a long-term partner in the journey for ‘feel-great skin’.

Looking ahead, the success of startups like Skin + Me poses key questions on the future of therapeutics. Could this model of direct-to-consumer therapeutics be proliferated across other facets of healthcare and pharmaceutical industries? If the rave reviews Skin + Me have received thus far are anything to go by, then D2C could indeed be the future. This may herald a wider shift in the pharmaceuticals industry, moving it more closely to a personalized model that puts the consumer’s needs and preferences at its core.

To stay updated on Skin + Me’s innovative journey, you can follow them on Twitter, Facebook, and LinkedIn. You can also explore their range of services on their website.

Want to supercharge your brand’s visibility within the UK tech industry? Reach startup founders, investors, and C-level executives with sponsored articles on Connect with us and discover how our advertising solutions can propel your brand to new heights. Explore our Sponsored Articles & Partnerships Program here.

Read more from UKT News:  Is Cyber Security Marketplace The Future Of IT-Solution Procurement?

UKT News is a media platform owned by Unstructured Media, providing the latest news and insights on UK technology and startup scenes. The website offers readers with daily updates on the latest industry developments, as well as featuring exciting startups and advertising opportunities.

Leave a Reply

Your email address will not be published.